Equianalgesic Conversion and Dosing Guidelines for Oral Oxycodone and Morphine

Conversion Ratio

• The Centers for Disease Control and Prevention (CDC) recommends a conversion factor of 1.5 : 1 (oxycodone : morphine), so that 10 mg oral oxycodone ≈ 15 mg oral morphine for adult patients. 1

Initial Dosing for Opioid‑Naïve Patients

• The National Comprehensive Cancer Network (NCCN) advises that opioid‑naïve adults with pain intensity ≥ 4 should start with 5–15 mg oral morphine (or an equianalgesic dose); therefore, a 10 mg oral oxycodone dose corresponds to the upper end of this recommended initial range. 2

Opioid Rotation (Cross‑Tolerance Adjustment)

• When switching a patient from one opioid to another, clinicians should reduce the calculated equianalgesic dose by 25–50 % to compensate for incomplete cross‑tolerance. This recommendation is supported by CDC and Praxis Medical Insights consensus statements. 1, 3
• The above dose‑reduction does not apply when simply determining the equianalgesic dose for initial prescribing in opioid‑naïve patients. 1

Assessment and Titration After Initial Dose

• The NCCN recommends assessing analgesic efficacy and side‑effects every 60 minutes after an oral opioid dose in adult patients. 4
• If pain remains ≥ 4 or treatment goals are unmet, the NCCN advises administering an additional 50–100 % of the previous dose and reassessing after the same interval. 4

Breakthrough (Rescue) Dosing

• For rescue analgesia, guidelines suggest prescribing breakthrough doses equal to 10–20 % of the total 24‑hour opioid dose. This recommendation is derived from consensus guidance (Praxis Medical Insights). 1, 3

Opioid Dosing and Pharmacology for Morphine‑to‑Oxycodone Conversion

Initial Dosing Recommendations for Opioid‑Naïve Patients

• The National Comprehensive Cancer Network (NCCN) recommends that the initial opioid dose for opioid‑naïve patients be 5–15 mg oral morphine equivalent; a 10 mg oral oxycodone dose (equivalent to 15 mg oral morphine) falls within this range【5】【6】.

Analgesic Agent Characteristics

• According to NCCN guidelines, both morphine and oxycodone are short‑acting opioid agonists that can be readily titrated, making them preferred options for acute pain management【5】.

Metabolism and Safety Considerations

• NCCN advises caution when using morphine in patients with renal impairment because of accumulation of morphine‑6‑glucuronide, whereas oxycodone is primarily metabolized in the liver via cytochrome P450 enzymes【5】.